“Pre-eclampsia is thought to be the most common glomerular disease worldwide, affecting up to 5% of pregnancies, and up to 11% of women have pregnancies complicated by hypertension,” says Dr. Kate Bramham. “Hypertensive disorders of pregnancy have now become the leading cause of pregnancy-associated acute kidney injury, and its incidence is rising in both...
Dr. Caroline Lamarche will outline her work on modified cells and alternative treatment for end-stage kidney disease in her talk, “CAR-T reg therapy and the possibilities in transplantation.” Dr. Domínguez-Gil will discuss the challenges of providing kidney transplants in low-resource countries in her talk, “Promoting equitable deceased donor transplantation in developing countries,” and highlight strategies...
The YNC is pleased to announce this year’s recipients of the Young Nephrologists Awards: Dr. Julian A. Marschner (Germany) - best basic science abstract, “A kidney-on-the-chip approach using primary human tubular cells in a 3D co-culture system.” Dr. Marschner is currently completing postdoctoral work developing complex in vitro assays to gain mechanistic insights into processes of...
The ISN, alongside its partners in the Global Coalition for Circulatory Health (GCCH), contributed to MediaPlanet’s cardiovascular health campaign with the article “Circulatory diseases – a growing global problem,” to be published in the Guardian newspaper. Read the article here from tomorrow, March 30. Circulatory diseases are the world’s leading cause of disability and death and...
The ISN and KDIGO have partnered to create tools on CKD early identification and intervention for kidney health professionals, primary care physicians, and nurses working in primary care settings. Access the toolkit here. The ISN-KDIGO CKD Early Identification & Intervention Toolkit includes quick guides, infographics, teaching tools, as well as research articles, webcasts, and reports. The toolkit...
Raising-the-Curtain Sessions WCN’21 launches with special Raising-the-Curtain sessions connecting ISN’s ten global regions to highlight issues and initiatives in each area. Starting with the ISN Oceania and South East Asia Region and ending with the ISN Latin America Region, take a world tour from East to West between April 12-14. Discover the complete program and find...
As part of ISN’s global campaign to prioritize COVID-19 vaccinations for the three million patients worldwide currently undergoing dialysis, the ISN held the webinar, “Prioritization of Dialysis Patients in National Covid-19 Vaccination Programs - Lessons Learned from Successful Campaigns,” on March 9, 2021. The webinar highlighted methods and results from campaigns carried out in Italy,...
The ISN Ravi Mehta AKI Fellowship was set up in honor of Dr. Ravindra Mehtain in collaboration with his friends and colleagues to recognize his leadership and contribution to global health and education. The ISN invites you to make a financial contribution to the Ravi Mehta AKI Fellowship. Donations are used to: Support a Fellow: Training in Acute Kidney...
The Estonian Society of Nephrology (ESN) will participate in the Raising-the-Curtain sessions for the ISN Eastern and Central Europe Region at WCN’21 on Tuesday, April 13, at 6 .a.m. EDT (convert to your time zone here). The ISN has enjoyed a constructive collaboration with the ESN since 1995, notably supporting the biannual Baltic Nephrology Societies...
The Nephrology Society of Thailand (NST) has joined the ISN as a Collective-Member Society, further strengthening a mutual commitment to advancing kidney care in South East Asia. Established in 1974 and currently presided by Prof. Surasak Kantchuwessiri, the NST shares ISN’s objectives to promote nephrology education and kidney disease research to members and beyond. The...
Professor Helal: A Decade of Professional Advancement through ISN Initiatives Prof. Helal’s professional journey is one of many to be showcased on the ISN@Work Gallery launching at WCN’21. This gallery will highlight several ISN members whose work and professional development have benefited from ISN granting programs, as well as those who tirelessly advocate to raise awareness...
Why do some patients receiving hemodialysis remain cheerful, hopeful, outward-looking, and enjoy a rich life, while others suffer debilitating depression and other emotional problems? Can whatever makes some patients more resilient be “bottled” and given to those less resilient to help them? These are the questions that Chris McIntyre, professor of medicine, medical biophysics, and...
Around 10% of the world’s population is thought to be affected by chronic kidney disease (CKD). Professor Sophie de Seigneux believes that understanding how patients with acute kidney injury (AKI) go on to develop CKD could be a vital step in reducing this burden. She says: “There are currently very few treatments that are able...
Hemodialysis is life-sustaining therapy for many patients with chronic kidney disease, but choosing how to access a patient’s blood for treatment presents pros and cons, depending on their situation. “We have seen that a ‘one-size-fits-all’ approach to medicine, and for hemodialysis vascular access, does not necessarily work for all,” says Charmaine Lok, Professor of Medicine...
It is well-established that African Americans are more than three times as likely to develop end-stage renal disease (ESRD) than non-Hispanic white Americans. Research also shows that Black people living in sub-Saharan Africa have a similarly high predisposition to developing chronic kidney disease (CKD). “This increased risk of CKD is attributable in part to variants...
Most research into kidney health, disease, its progression, and treatment has been based on the male model and does not take into account the impact of sex and gender, according to Professor Sofia Ahmed. In her plenary, keynote presentation at WCN’21, Prof. Ahmed, from the Cumming School of Medicine at the University of Calgary, Canada,...
The Partnership for Health System Sustainability Resilience (PHSSR), founded by the World Economic Forum (WEF), the London School of Economics, and AstraZeneca, is holding a summit from March 15-19 2021. Registration details to follow shortly. “Improving the effectiveness of care” will bring together academia and the public and private sectors to share insights from nine months...
Help expand trial participation within the nephrology community: Join colleagues online for a lively exchange of ideas on February 16 at 9 p.m. ET. #NephTrials The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering on the #NephTrials initiative to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials. The #NephTrials initiative is an exciting new series...
Throughout 2021, the ISN will present a series of interviews with our Collective-Member Societies. For this edition, we interviewed Rudolf P. Wüthrich, President of the Swiss Society of Nephrology. This society has been an ISN Collective-Member for over a decade. In 2019, the ISN launched a new partnership with the Swiss Society of Nephrology and the...
Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlights: Daily, weekly, or monthly cholecalciferol dosing regimens are similarly effective in children with CKD View the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN...
